GOOGLE, as it’s often called, has entered the next chapter in its evolution. Incoming CFO Anat Ashkenazi will oversee and drive the company’s investments in generative artificial intelligence. She previously worked at Eli Lilly, now the most valuable drugmaker in the world, thanks to its weight loss drugs Mounjaro and Zepbound.
Alphabet is already on a solid footing after delivering an excellent earnings beat in April: Revenue increased 15% from a year earlier, the fastest rate of growth since early 2022, and they announced their first dividend plus a $70 billion buyback. It helps to evolve into an exciting new AI world with an already well-oiled machine generating billions of dollars.
- We like GOOGL from a risk/reward perspective into $US20 dips which it often seems to deliver.
MM is bullish towards GOOGL
Add To Hit List
